Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE: 300026)

Tianjin Chase Sun Pharmaceutical Co.,Ltd Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 6, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	9,583	12,738	17,064	23,523	13,759	10,550
Market Cap Growth	-43.73%	-25.35%	-27.46%	70.96%	30.42%	14.88%
Enterprise Value	9,661	13,109	18,344	24,054	14,108	9,989
Last Close Price	3.19	4.21	5.60	7.67	4.45	3.37
PE Ratio	31.19	24.74	26.69	33.36	23.40	24.10
PS Ratio	1.70	2.09	2.57	3.07	2.12	2.11
PB Ratio	1.09	1.44	2.02	2.96	1.86	1.49
P/FCF Ratio	8.70	10.77	-684.58	-82.29	-37.48	-28.14
P/OCF Ratio	6.47	8.32	22.89	60.07	69.96	48.82
EV/Sales Ratio	1.70	2.15	2.76	3.14	2.17	2.00
EV/EBITDA Ratio	16.31	16.44	18.83	19.77	15.27	13.58
EV/EBIT Ratio	37.14	25.43	25.32	23.99	19.22	17.23
EV/FCF Ratio	8.77	11.08	-735.97	-84.15	-38.43	-26.64
Debt / Equity Ratio	0.18	0.17	0.25	0.25	0.16	0.05
Debt / EBITDA Ratio	2.64	1.80	2.03	1.55	1.25	0.50
Debt / FCF Ratio	1.42	1.30	-83.88	-6.87	-3.16	-0.99
Asset Turnover	0.46	0.50	0.55	0.70	0.70	0.63
Inventory Turnover	1.33	1.35	1.61	2.40	2.47	2.16
Quick Ratio	2.83	2.89	1.79	2.46	1.72	2.61
Current Ratio	4.10	4.29	2.76	3.31	2.44	3.51
Return on Equity (ROE)	3.45%	5.79%	7.57%	8.74%	7.74%	5.99%
Return on Assets (ROA)	1.33%	2.63%	3.73%	5.75%	4.93%	4.55%
Return on Capital (ROIC)	1.55%	3.08%	4.42%	6.79%	5.74%	5.09%
Earnings Yield	3.21%	3.98%	3.66%	2.92%	4.17%	3.82%
FCF Yield	11.50%	9.29%	-0.15%	-1.22%	-2.67%	-3.55%
Dividend Yield	0.93%	0.71%	0.54%	0.52%	0.90%	1.48%
Payout Ratio	46.10%	30.53%	30.56%	22.96%	31.73%	17.42%
Buyback Yield / Dilution	-2.62%	-0.26%	0.53%	0.98%	-4.96%	4.52%
Total Shareholder Return	-1.68%	0.46%	1.06%	1.50%	-4.06%	6.00%

Source: S&P Capital IQ. Standard template. Financial Sources.